Wegener's Granulomatosis Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Systemic Lupus Erythematosus; Psoriasis; Behcet's Disease; Wegener's Granulomatosis; Takayasu's Disease; Crohn's Disease; Ulcerative Colitis; Autoimmune Hepatitis; Sclerosing CholangitisIntervention: Drug: Interleukin 2Sponsors: Assistance Publique - Hôpitaux de Paris; ILTOO PharmaRecruiting - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2013 Category: Research Source Type: clinical trials
Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Systemic Lupus Erythematosus; Psoriasis; Behcet's Disease; Wegener's Granulomatosis; Takayasu's Disease; Crohn's Disease; Ulcerative Colitis; Autoimmune Hepatitis; Sclerosing CholangitisIntervention: Drug: Interleukin 2Sponsors: Assistance Publique - Hôpitaux de Paris; ILTOO PharmaNot yet recruiting - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2013 Category: Research Source Type: clinical trials
Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Systemic Lupus Erythematosus; Psoriasis; Behcet's Disease; Wegener's Granulomatosis; Takayasu's Disease; Crohn's Disease; Ulcerative Colitis; Autoimmune Hepatitis; Sclerosing CholangitisIntervention: Drug: Interleukin 2Sponsors: Assistance Publique - Hôpitaux de Paris; ILTOO PharmaRecruiting - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2013 Category: Research Source Type: clinical trials
Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Systemic Lupus Erythematosus; Psoriasis; Behcet's Disease; Wegener's Granulomatosis; Takayasu's Disease; Crohn's Disease; Ulcerative Colitis; Autoimmune Hepatitis; Sclerosing CholangitisIntervention: Drug: Interleukin 2Sponsors: Assistance Publique - Hôpitaux de Paris; ILTOO PharmaNot yet recruiting - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2013 Category: Research Source Type: clinical trials
Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Systemic Lupus Erythematosus; Psoriasis; Behcet's Disease; Wegener's Granulomatosis; Takayasu's Disease; Crohn's Disease; Ulcerative Colitis; Autoimmune Hepatitis; Sclerosing CholangitisIntervention: Drug: Interleukin 2Sponsors: Assistance Publique - Hôpitaux de Paris; ILTOO PharmaRecruiting - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2013 Category: Research Source Type: clinical trials
